Impact of the COVID-19 Pandemic on Esophagogastroduodenoscopy and Gastric Cancer Claims in South Korea: A Nationwide, Population-Based Study
0
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Purpose: There has been little information about the impact of coronavirus disease 2019 (COVID-19) pandemic on esophagogas troduodenoscopy (EGD) and gastric cancer claims. This study aimed to measure the impact of COVID-19 pandemic on EGD and gastric cancer claims in South Korea. Materials and Methods: This nationwide, population-based study compared the claims data of EGD, gastric cancer, early gastric cancer (EGC), advanced gastric cancer (AGC) and gastric cancer operation in 2020 and 2021 (COVID-19 era) to those in 2019 (be fore COVID-19 pandemic). Results: The annual claims of EGD, gastric cancer, EGC, and AGC were reduced by 6.3%, 5.0%, 4.7%, and 3.6% in 2020 and by 2.2%, 1.0%, 0.6%, and 1.9% in 2021, respectively, compared to 2019. The amount of annual claims of gastric cancer operation was reduced by 8.8% in 2020, but increased by 0.9% in 2021, compared to those in 2019. The monthly claims of EGD, gastric cancer, EGC, AGC, and gastric cancer operation were mainly reduced in the first epidemic wave of COVID-19, but decreased in the 2nd to 4th epidemic wave. Compared to 2019, the monthly claim of EGD, gastric cancer, EGC, AGC, and gastric cancer operation were reduced by 28.8%, 14.3%, 18.1%, 9.2%, and 5.8% in March 2020 and by 17.2%, 10.8%, 10.3%, 7.2%, and 35.4% in April 2020, respectively. Conclusion: Negative impact of the COVID-19 pandemic on EGD, gastric cancer, EGC, AGC, and gastric cancer operation was worst during the first surge of COVID-19, but decreased in the 2nd to 4th epidemic wave of the disease in 2020 and 2021.
Abstract
Purpose: There has been little information about the impact of coronavirus disease 2019 (COVID-19) pandemic on esophagogas troduodenoscopy (EGD) and gastric cancer claims. This study aimed to measure the impact of COVID-19 pandemic on EGD and gastric cancer claims in South Korea. Materials and Methods: This nationwide, population-based study compared the claims data of EGD, gastric cancer, early gastric cancer (EGC), advanced gastric cancer (AGC) and gastric cancer operation in 2020 and 2021 (COVID-19 era) to those in 2019 (be fore COVID-19 pandemic). Results: The annual claims of EGD, gastric cancer, EGC, and AGC were reduced by 6.3%, 5.0%, 4.7%, and 3.6% in 2020 and by 2.2%, 1.0%, 0.6%, and 1.9% in 2021, respectively, compared to 2019. The amount of annual claims of gastric cancer operation was reduced by 8.8% in 2020, but increased by 0.9% in 2021, compared to those in 2019. The monthly claims of EGD, gastric cancer, EGC, AGC, and gastric cancer operation were mainly reduced in the first epidemic wave of COVID-19, but decreased in the 2nd to 4th epidemic wave. Compared to 2019, the monthly claim of EGD, gastric cancer, EGC, AGC, and gastric cancer operation were reduced by 28.8%, 14.3%, 18.1%, 9.2%, and 5.8% in March 2020 and by 17.2%, 10.8%, 10.3%, 7.2%, and 35.4% in April 2020, respectively. Conclusion: Negative impact of the COVID-19 pandemic on EGD, gastric cancer, EGC, AGC, and gastric cancer operation was worst during the first surge of COVID-19, but decreased in the 2nd to 4th epidemic wave of the disease in 2020 and 2021.
참고문헌 (19)
- Jee Y, "A COVID-19 mortality prediction model for Korean patients using nationwide Korean disease control and prevention agency database", Sci Rep, 12, pp.3311~ (2022)
- Sultan S, "AGA rapid recommendations for gastrointestinal procedures during the COVID-19 pandemic", Gastroenterology, 159, pp.739~758 (2020)
- 이기쁨, "Guidelines for Cancer Care during the COVID-19 Pandemic in South Korea", Cancer Research and Treatment, 53(2), pp.323~329 (2021), 대한암학회[DOI]
- Hesary FB, "The impact of the COVID-19 epidemic on diagnosis, treatment, concerns, problems, and mental health in patients with gastric cancer", J Gastrointest Cancer, 53, pp.797~804 (2022)
- Solaini L, "Consequences of the COVID-19 pandemic on the diagnosis and treatment of gastric cancer in referral centers in Italy", Tumori, 109, pp.121~128 (2023)
- Chiu HM, "Mitigating the impact of COVID-19 on colorectal cancer screening : organized service screening perspectives from the Asia-Pacific region", Prev Med, 151, pp.106622~ (2021)
- Kim L, "A guide for the utilization of Health Insurance Review and Assessment Service national patient samples", Epidemiol Health, 36, pp.e2014008~ (2014)
- 김지애, "Towards Actualizing the Value Potential of Korea Health Insurance Review and Assessment (HIRA) Data as a Resource for Health Research: Strengths, Limitations, Applications, and Strategies for Optimal Use of HIRA Data", Journal of Korean Medical Science, 32(5), pp.718~728 (2017), 대한의학회
- Lee Kyeongmin, "Impact of the COVID-19 Pandemic on Gastric Cancer Screening in South Korea: Results From the Korean National Cancer Screening Survey (2017–2021)", Journal of Gastric Cancer, 22(4), pp.264~272 (2022), 대한위암학회[DOI]
- Jeon J, "Evolution of responses to COVID-19and epidemiological characteristics in South Korea", Int J Environ Res Public Health, 19, pp.4056~ (2022)
- Gralnek IM, "ESGE and ESGENA position statement on gastrointestinal endoscopy and the COVID-19 pandemic", Endoscopy, 52, pp.483~490 (2020)
- Longcroft-Wheaton G, "Data from a large Western centre exploring the impact of COVID-19pandemic on endoscopy services and cancer diagnosis", Frontline Gastroenterol, 12, pp.193~199 (2021)
- Buscarini E, "Changes in digestive cancer diagnosis during the SARS-CoV-2 pandemic in Italy : a nationwide survey", Dig Liver Dis, 53, pp.682~688 (2021)
- "South Korea announces the roadmap for gradual return to normal (10.29)"[URL]
- DE Rosa M, "Could diagnostic and therapeutic delay affect the prognosis of gastrointestinal primary malignancies in the COVID-19 pandemic era?", Minerva Surg, 76, pp.467~476 (2021)
- Fligor SC, "Gastrointestinal malignancies and the COVID-19 pandemic : evidence-based triage to surgery", J Gastrointest Surg, 24, pp.2357~2373 (2020)
- Galasso V, "Gender differences in COVID-19 attitudes and behavior : panel evidence from eight countries", Proc Natl Acad Sci U S A, 117, pp.27285~27291 (2020)
- Otterbring T, "Pandemic prevention and personality psychology : gender differences in preventive health behaviors during COVID-19 and the roles of agreeableness and conscientiousness", J Saf Sci Resil, 3, pp.87~91 (2022)
- 변선주, "Analysis of Surgical Pathology Data in the HIRA Database: Emphasis on Current Status and Endoscopic Submucosal Dissection Specimens", Journal of Pathology and Translational Medicine, 50(3), pp.204~210 (2016), 대한병리학회[DOI]